Harmony Biosciences Holdings IPO · $173M raised

Harmony Biosciences Holdings is a biopharmaceutical company dedicated to addressing unmet medical needs in rare neurological diseases. Their primary focus is on developing and commercializing therapies for conditions such as narcolepsy. They aim to improve the lives of patients by providing novel treatment options.